Skip to content

Clinical trials

Phase 4 Epilepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 4 Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20023
20034
20043
200510
200611
20074
20087
20093
20105
20112
20124
20133
20142
20158
20165
20175
20185
20192
20202
20214
20225
20235
20245
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Unknown status18
Terminated12
Recruiting6
Withdrawn3
Not yet recruiting3
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Korea Inc.6
GlaxoSmithKline5
UCB Pharma5
Eisai Limited3
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.3
University of Cincinnati3
Cyberonics, Inc.2
Eisai Inc.2
Kimford Jay Meador2
Nasim Tabrizi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy117
Seizures25
Epilepsies, Partial13
Nervous System Diseases6
Anxiety Disorders5
Drug Resistant Epilepsy4
Attention Deficit Disorder with Hyperactivity3
Brain Neoplasms3
Headache3
Brain Diseases2

Trials

Showing 51 to 75 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.